Our observations in primary T-ALL were supported by analysis of RNA-seq data for 20 T-ALL cell lines from the Cancer Cell Line Encyclopedia (CCLE) (34), which showed a similar distribution of TET2 down-regulation and silencing (Fig. 1G). The gene discussed is TET2; the disease is cancer.